Search results

Biogen BIIB reported first-quarter 2026 adjusted earnings per share (EPS) of $3.57, which significantly beat the Zacks Consensus Estimate of $2.95. Earnings rose 18% year over year.

The adjusted EPS

Northern Trust Corporation’s NTRS  first-quarter 2026 earnings per share (EPS) of $2.71 beat the Zacks Consensus Estimate of $2.37. In the prior-year quarter, the company reported an EPS of $1.90.

On Tuesday, Tesla (TSLA) delivered earnings above Wall Street expectations. Adjusted EPS came in at $0.41, beating the $0.34 analyst forecast and marking a second consecutive earnings beat. Overall,

West Pharmaceutical Services, Inc. WST delivered adjusted first-quarter 2026 earnings per share (EPS) of $2.13, which moved up 46.9% year over year. The figure topped the Zacks Consensus Estimate by

Molina Healthcare Inc. MOH reported first-quarter 2026 adjusted earnings per share (EPS) of $2.35, which beat the Zacks Consensus Estimate of $1.57. The bottom line declined 61.3% from the year-ago

Ecolab Inc. ECL has reported first-quarter 2026 adjusted earnings per share (EPS) of $1.70, up 13.3% year over year. The metric was in line with the Zacks Consensus Estimate.

GAAP EPS for the

Generac Holdings Inc. GNRC reported first-quarter 2026 adjusted earnings per share (EPS) of $1.80, which beat the Zacks Consensus Estimate of $1.33. GNRC registered an adjusted EPS of $1.26 in the

AbbVie Inc. ABBV reported first-quarter 2026 adjusted EPS of $2.65, which beat the Zacks Consensus Estimate of $2.62. The reported figure also exceeded the company’s guidance of $2.56-$2.60 issued

Investors may be taking a fresh look at General Motors GM) and Ford Motor’s F) stock after their stronger-than-expected Q1 earnings and upgraded guidance.

GM topped Wall Street’s EPS expectations

Bristol-Myers Squibb Company BMY reported first-quarter 2026 adjusted earnings per share (EPS) of $1.58, which beat the Zacks Consensus Estimate of $1.44. However, the reported EPS was down 12% from

Cardinal Health, Inc. CAH reported third-quarter fiscal 2026 adjusted earnings per share (EPS) of $3.17, which beat the Zacks Consensus Estimate of $2.80 by 13.2%. The bottom line also improved 35%

DexCom, Inc. DXCM reported first-quarter 2026 adjusted earnings per share (EPS) of 56 cents, which beat the Zacks Consensus Estimate of 47 cents by 19.2%. The company reported adjusted EPS of 32

Krystal Biotech KRYS reported first-quarter 2026 earnings per share (EPS) of $1.83, which surpassed the Zacks Consensus Estimate of $1.45. The reported EPS was up from $1.20 in the year-ago quarter.

The Ensign Group, Inc. ENSG reported a first-quarter 2026 adjusted EPS of $1.85, which beat the Zacks Consensus Estimate by 3.4%. The bottom line improved 21.7% year over year.

Operating revenues

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure